Award recordCONTRACT

TAKEDA PHARMACEUTICALS AMERICA, INC.

PIID 36C26124N0323· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2024· $44,756 net obligations· UEI DDEVYUAXJ624· IL

Description

CINRYZE

First action · last action
2023-12-14 · 2024-06-27
Transactions
2
First transaction's obligation
$89,399
Base + all options value (sum of deltas)
$44,756
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D50492
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$89,399$0Base award · 2023-12-14 · this action $89,399 · running total $89,399Modification P00001 · 2024-06-27 · this action -$44,643 · running total $44,756
  • Base2023-12-14+$89,399= $89,399
  • Mod P000012024-06-27-$44,643= $44,756
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2023-12-14+$89,399$89,399CINRYZE
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-06-27−$44,643$44,756CINRYZE

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI DDEVYUAXJ624)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0840245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$19,139FY2026
36E79726A0023NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C24526N0835245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$34,605FY2026
36F79726D0181NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26026P0420260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$107,540FY2026
36C26126P0581261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$27,250FY2026

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26124N0323_3600_V797D50492_3600 · retrieved 2026-09-26.